Rite Aid Corp - Company Profile
Powered by 
All the data and insights you need on Rite Aid Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Rite Aid Corp Strategy Report
- Understand Rite Aid Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Rite Aid Corp (Rite Aid) is a retail drugstore chain that sells prescription drugs and other merchandise such as over-the-counter medications, personal care items, health and beauty aids, cosmetics, food and beverages, greeting cards, household items, grocery, pet care and seasonal merchandise. Rite Aid’s service portfolio includes pharmacy-related solutions, including fully integrated mail order and specialty pharmacy services. The company’s stores are integrated into a common pharmacy system, which enables customers to fill or refill prescriptions in any of its stores throughout the US. It operates through subsidiaries and retail drugstores in the US. Through pharmacy services it provides pharmaceutical solutions for its clients such as employers, government employee groups, insurance companies, health plans, unions, managed medicaid plans, medicare plans, and other sponsors of health benefit plans, and individuals throughout the US. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US.
Headquarters
United States of America
Address
1200 Intrepid Avenue, 2nd Floor, Philadelphia, Pennsylvania, 19112
Website
www.riteaid.com
Telephone
1 717 7612633
No of Employees
47,000
Industry
Retailing
Ticker Symbol & Exchange
RADCQ (OTC)
Revenue (2022)
$24.1B
-1.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-39.3%
(2022 vs 2021)
Market Cap*
$5.1M
Net Profit Margin (2023)
XYZ
-42.0%
(2022 vs 2021)
* As of and is in US$
Rite Aid Corp premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Health and Beauty Aids | Insurance Services |
| Vitamins and Supplements | Pharmacy Services |
| Baby, Kids and Toy Products | Healthcare Services |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In March, the company partnered with Copia to enhance its waste reduction initiatives and create a significant impact in the California communities it serves. |
| 2024 | Asset Disposal | In February, the company announced the sale of its Elixir Solutions business for US $576.5 million to MedImpact Healthcare Systems, Inc. |
| 2024 | Regulatory Approval | In January, the company received approval from the US Bankruptcy Court for the District of New Jersey for the sale of its Elixir Solutions Business to MedImpact Healthcare Systems Inc. |
Competitor Comparison
| Key Parameters | Rite Aid Corp | Walmart Inc | CVS Health Corp | The Kroger Co | Walgreens Boots Alliance Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Philadelphia | Bentonville | Woonsocket | Cincinnati | Deerfield |
| State/Province | Pennsylvania | Arkansas | Rhode Island | Ohio | Illinois |
| No. of Employees | 47,000 | 2,100,000 | 300,000 | 430,000 | 206,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bruce G. Bodaken | Chairman | Executive Board | 2018 | 70 |
| Jeffrey S. Stein | Chief Restructuring Officer; Chief Executive Officer; Director | Executive Board | 2023 | - |
| Matthew Schroeder | Chief Financial Officer; Executive Vice President | Senior Management | 2019 | 53 |
| Jeanniey Walden | Chief Marketing Officer; Senior Vice President | Senior Management | 2023 | - |
| Thomas Sabatino | Chief Legal Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward